Skip to content
Menu

NRx Pharmaceuticals, Inc. NRXP

Full chart Compare
Set alert

Price alert · NRXP

All alert types
2.55 USD -0.25 (-8.93%)

Regular-session close

2.55 0.00 0.00%

After hours · Nov 19, 7:16 PM ET

2.52 Day range 2.88
1.62 52-week range 5.06
YTD
-5.90%
1 year
+19.72%

Revenue & Expenses

Revenue Profit Costs
Gross Profit$720.00KNet Loss$28.62MCost of Revenue$505.00KExpenses$29.34MSelling, General & Admin$13.06MResearch & Development$3.78MOther Operating Expenses$106.00KInterest Expense$671.00KOther Expenses$11.73MRevenue$1.23M

Latest period ending Dec 31, 2025 · select a line to chart its full history

NRXP annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.23M0000
720.00K0000
-16.22M-18.50M-27.84M-44.34M-115.80M
-28.62M-25.13M-30.15M-39.75M-93.06M
-1.34-2.36-3.98-6.00-19.80
NRXP annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
7.80M1.44M4.59M20.05M27.61M
12.96M3.65M7.32M25.82M32.73M
28.89M26.87M19.05M18.41M11.92M
631.00K6.58M9.16M10.53M518.00K
-15.94M-23.22M-11.73M7.41M20.81M
NRXP annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-14.11M-10.64M-21.66M-39.76M-37.70M
-2.81M0-3.00K-10.00K-7.00K
23.28M7.49M6.20M32.21M63.46M
6.35M-3.15M-15.46M-7.55M25.75M